Trivia Cafe
76

What new vaccine, targeting the Zika virus, entered Phase 3 clinical trials in December 2025?

Learn More

ZIKAVAX - current events illustration
ZIKAVAX — current events

The development of a vaccine against the Zika virus has been a global health priority, particularly given the virus's association with severe neurological complications. The Zika virus, primarily transmitted by Aedes mosquitoes, can cause mild symptoms in most people, such as fever, rash, joint pain, and conjunctivitis. However, infection during pregnancy poses a significant